Here, we confirmed these observations while additionally showing that ATRvD1 reverts fibroblast differentiation and inhibits the release of EVs in vivo and in vitro, reduces fibronectin deposition, and abolishes angiogenesis in HCP tissues challenged by BLM. This evidence concerns the gene FN1 and hereditary coproporphyria.